These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10930300)

  • 1. Changes of cytokines during the course of graft-versus-host disease following bone marrow transplantation: a case report.
    Takatsuka H; Takemoto Y; Okada M; Sawada A; Katsuno T; Wada H; Kakishita E
    Cytokine; 2000 Aug; 12(8):1225-7. PubMed ID: 10930300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines, adhesion molecules (E-selectin and VCAM-1) and graft-versus-host disease.
    Lange A; Klimczak A; Karabon L; Suchnicki K
    Arch Immunol Ther Exp (Warsz); 1995; 43(2):99-105. PubMed ID: 8744723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral eicosapentaenoic acid for complications of bone marrow transplantation.
    Takatsuka H; Takemoto Y; Iwata N; Suehiro A; Hamano T; Okamoto T; Kanamaru A; Kakishita E
    Bone Marrow Transplant; 2001 Oct; 28(8):769-74. PubMed ID: 11781629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of serum cytokines after allogeneic bone marrow transplantation: interleukin-5 as a potential marker of acute graft-versus-host disease.
    Imoto S; Oomoto Y; Murata K; Das H; Murayama T; Kajimoto K; Sugimoto T; Gomyo H; Nakagawa T; Nishimura R; Koizumi T
    Int J Hematol; 2000 Jul; 72(1):92-7. PubMed ID: 10979216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Eradication of adult T-cell leukemia cells and maintenance of remission by the graft-versus-leukemia effect after allogeneic bone marrow transplantation].
    Ota K; Hashino S; Shimizu K; Yonezumi M; Chiba K; Kondo T; Suzuki S; Imamura M; Asaka M
    Rinsho Ketsueki; 2004 Sep; 45(9):1044-7. PubMed ID: 15510833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [TNF-alpha in allogeneic bone marrow transplantation. Significance for immunologic reconstitution, acute graft versus host disease and risk of complications after bone marrow transplantation].
    Holler E
    Fortschr Med; 1991 Apr; 109(12):263-6. PubMed ID: 1855757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic microangiopathy following allogeneic bone marrow transplantation.
    Takatsuka H; Takemoto Y; Okamoto T; Fujimori Y; Tamura S; Wada H; Okada M; Kanamaru A; Kakishita E
    Bone Marrow Transplant; 1999 Aug; 24(3):303-6. PubMed ID: 10455370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential expression of adhesion and costimulatory molecules in graft-versus-host disease target organs after murine bone marrow transplantation across minor histocompatibility antigen barriers.
    Eyrich M; Burger G; Marquardt K; Budach W; Schilbach K; Niethammer D; Schlegel PG
    Biol Blood Marrow Transplant; 2005 May; 11(5):371-82. PubMed ID: 15846291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The absence of donor-derived IL-13 exacerbates the severity of acute graft-versus-host disease following allogeneic bone marrow transplantation.
    Hildebrandt GC; Choi SW; Mueller G; Olkiewicz KM; Moore BB; Cooke KR
    Pediatr Blood Cancer; 2008 Apr; 50(4):911-4. PubMed ID: 17455319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similarity between eruptions induced by sulfhydryl drugs and acute cutaneous graft-versus-host disease after bone marrow transplantation.
    Takatsuka H; Takemoto Y; Yamada S; Mori A; Wada H; Fujimori Y; Okamoto T; Kanamaru A; Kakishita E
    Hematology; 2002 Feb; 7(1):55-7. PubMed ID: 12171778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome.
    Takatsuka H; Takemoto Y; Yamada S; Wada H; Tamura S; Fujimori Y; Okamoto T; Suehiro A; Kanamaru A; Kakishita E
    Bone Marrow Transplant; 2000 Aug; 26(4):419-26. PubMed ID: 10982289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome following allogeneic bone marrow transplantation.
    Takatsuka H; Wakae T; Mori A; Okada M; Suehiro A; Okamoto T; Kakishita E
    Bone Marrow Transplant; 2002 Jun; 29(11):907-11. PubMed ID: 12080356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute disseminated encephalomyelitis (ADEM) after allogeneic bone marrow transplantation for acute myeloid leukemia.
    Tomonari A; Tojo A; Adachi D; Iseki T; Ooi J; Shirafuji N; Tani K; Asano S
    Ann Hematol; 2003 Jan; 82(1):37-40. PubMed ID: 12574963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the severity of intestinal graft-versus-host disease from leukotriene B4 levels after bone marrow transplantation.
    Takatsuka H; Yamada S; Okamoto T; Fujimori Y; Wada H; Iwata N; Kanamaru A; Kakishita E
    Bone Marrow Transplant; 2000 Dec; 26(12):1313-6. PubMed ID: 11223971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid treatment alters adhesion molecule and chemokine expression in experimental acute graft-vs.-host disease of the intestinal tract.
    Bouazzaoui A; Spacenko E; Mueller G; Huber E; Schubert T; Holler E; Andreesen R; Hildebrandt GC
    Exp Hematol; 2011 Feb; 39(2):238-249.e1. PubMed ID: 21108989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible association between the presence of interleukin-4-secreting cells and a reduction in the risk of acute graft-versus-host disease.
    Takabayashi M; Kanamori H; Takasaki H; Yamaji S; Koharazawa H; Taguchi J; Tomita N; Fujimaki K; Fujisawa S; Maruta A; Ishigatsubo Y
    Exp Hematol; 2005 Feb; 33(2):251-7. PubMed ID: 15676220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective monitoring of tumor necrosis factor alpha and interferon gamma to predict the onset of acute and chronic graft-versus-host disease after allogeneic stem cell transplantation.
    Ritchie D; Seconi J; Wood C; Walton J; Watt V
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):706-12. PubMed ID: 16125641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
    Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
    Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
    Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines as mediators of graft-versus-host disease.
    Cohen J
    Bone Marrow Transplant; 1988 May; 3(3):193-7. PubMed ID: 3048486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.